HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,851 | +5.2% | 43 | 0.0% | 0.00% | – |
| Q2 2023 | $3,661 | -98.8% | 43 | -99.3% | 0.00% | -100.0% |
| Q4 2021 | $304,000 | -24.8% | 5,734 | 0.0% | 0.02% | -24.2% |
| Q3 2021 | $404,000 | +122.0% | 5,734 | +213.3% | 0.03% | -8.3% |
| Q1 2020 | $182,000 | -52.8% | 1,830 | -45.5% | 0.04% | -41.9% |
| Q4 2019 | $386,000 | +21.8% | 3,360 | +33.3% | 0.06% | +10.7% |
| Q3 2019 | $317,000 | +4.6% | 2,520 | 0.0% | 0.06% | +3.7% |
| Q2 2019 | $303,000 | +24.2% | 2,520 | -10.0% | 0.05% | +3.8% |
| Q1 2019 | $244,000 | -30.1% | 2,800 | -19.9% | 0.05% | -38.1% |
| Q4 2018 | $349,000 | +25.1% | 3,496 | +43.4% | 0.08% | +40.0% |
| Q3 2018 | $279,000 | +65.1% | 2,438 | +29.0% | 0.06% | +57.9% |
| Q2 2018 | $169,000 | -30.2% | 1,890 | -42.8% | 0.04% | -32.1% |
| Q1 2018 | $242,000 | -6.6% | 3,302 | -25.9% | 0.06% | -3.4% |
| Q4 2017 | $259,000 | – | 4,457 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |